Does Hydrocortisone Increase Total Leukocyte Count?
Yes, hydrocortisone increases the total leukocyte count, with the magnitude of increase being dose-dependent: low-dose steroids cause minimal increases (0.3 × 10⁹/L), medium-dose steroids increase counts by approximately 1.7 × 10⁹/L, and high-dose steroids can elevate counts by up to 4.84 × 10⁹/L, with the peak effect occurring at 48 hours after administration 1.
Mechanism of Action
The increase in white blood cell count from hydrocortisone is primarily driven by neutrophilia rather than increases across all cell types. The mechanism involves:
- Decreased neutrophil adhesion to endothelial surfaces through reduced expression of adhesion molecules (Mac-1 and L-selectin) 2
- This causes neutrophils to demarginate from blood vessel walls and enter the circulation
- The effect is not due to increased production of white blood cells, but rather redistribution of existing cells
Importantly, while total leukocyte counts rise, you will typically see:
- Lymphopenia (decreased lymphocyte count)
- Eosinopenia (decreased eosinophil count)
- Neutrophilia (increased neutrophil count)
- Monocytopenia (decreased monocyte count in some cases)
Dose-Dependent Response
The magnitude of leukocytosis correlates directly with hydrocortisone dose 1:
- Low-dose (<50 mg hydrocortisone equivalent): Mean increase of 0.3 × 10⁹/L WBCs
- Medium-dose (50-200 mg): Mean increase of 1.7 × 10⁹/L WBCs
- High-dose (>200 mg): Mean increase of 4.84 × 10⁹/L WBCs
The peak effect occurs at 48 hours after steroid administration 1.
Clinical Implications
Interpreting Leukocytosis in Steroid-Treated Patients
When evaluating a patient on hydrocortisone who develops leukocytosis:
- Increases up to 4.84 × 10⁹/L within 48 hours of high-dose steroids are expected and do not necessarily indicate infection 1
- Any increase after low-dose steroids should raise suspicion for alternative causes (particularly infection) 1
- Increases exceeding 4.84 × 10⁹/L even with high-dose steroids suggest other pathology 1
Critical Pitfall
Corticosteroid-induced leukocytosis masks the predictive value of white blood cell counts for complications 3. In patients receiving dexamethasone or hydrocortisone, elevated WBC counts lose their ability to predict:
- Delayed cerebral ischemia
- Infectious complications
- Other inflammatory processes
This means you cannot rely on WBC trends alone to monitor for infection in steroid-treated patients—you must use additional clinical parameters and inflammatory markers.
Impact on Diagnostic Testing
High leukocyte counts from hydrocortisone administration can interfere with PCR-based blood diagnostics for bloodstream infections 4. The combination of:
- Leukocyte counts ≥26,900 cells/μL, AND
- Hydrocortisone administration
Creates a 67% risk of PCR test inhibition, leading to invalid results 4.
Duration of Effect
The leukocytosis from hydrocortisone is transient and resolves as the drug is metabolized. In patients not receiving ongoing steroids, WBC counts typically decrease during hospitalization 1, making the steroid-induced elevation even more apparent when it occurs.
Practical Guidance
When managing patients on hydrocortisone:
- Expect leukocytosis proportional to the dose administered
- Do not automatically attribute leukocytosis to infection within 48 hours of steroid administration
- Use clinical judgment and additional markers (procalcitonin, CRP, clinical signs) rather than WBC alone to diagnose infection
- Consider that very high WBC counts (>15-20 × 10⁹/L) even with high-dose steroids warrant investigation for infection
- Be aware that PCR-based blood culture diagnostics may fail in patients with steroid-induced leukocytosis